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BACKGROUND: Inflammation is a common process in endothelial dysfunction, characterized by an increase in the expression of endothelial cell adhesion molecules
and a decrease of nitric oxide production [1]. Evidence suggests that polyphenols may play a beneficial role in attenuating inflammation with implications on
atherosclerosis [2]. However, their mechanism of action is still not entirely understood due to their poor absorption and extensive intestinal and hepatic transformation [3].
OBJECTIVE: This study aims to evaluate the ability of some gut phenolic metabolites (i.e. protocatechuic, gallic, syringic and vanillic acid; PA, GA, SA, VA,
respectively) to reduce the adhesion of monocytes (THP-1) to endothelial cells (HUVECs), in a stimulated pro-inflammatory environment, and to decrease the production
of cell adhesion molecules (VCAM-1 and E-selectin), as potential markers involved in such modulation.
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METHODS:
RESULTS:
•GA and PA significantly decreased the adhesion of THP-1 to HUVECs at 1 µg
mL-1 (-18.0%; p=0.04 for GA, -29.5%; p=0.03 for PA) and 10 µg mL-1 (-59.3%;
p<0.001 for GA, -44.3%; p=0.001 for PrA) compared to TNF-. VA significantly
reduced the adhesion only at the maximum concentration (-20.8%; p<0.005). No
effect was observed after SA supplementation.
1Data are expressed as mean  SEM. Bars graph with different letters are significantly different (p≤0.05)
GA, gallic acid; PA, protocatechuic acid; SA, syringic acid; VA, vanillic acid
CONCLUSION:
In conclusion, these preliminary results seem to support the capacity of gut phenolic metabolites to modulate the endothelial cell adhesion process. The reduction in the 
adhesion process seems to be driven by a decrease of E-selectin levels but not VCAM-1. Ongoing experiments are attempting to clarify the mechanisms of action of each
compound involved in the above observations.
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• Day 1-Preparation of 96 wells plate (2x104 HUVEC per well);
• Day 2-Labelling of THP-1 cells with CellTrackerTM Green CMFDA,
addition of THP-1 (2x105 cells/well) and TNF- (100 ng mL-1) to HUVEC,
and incubation for 24h;
• Day 3-Incubation with PA, GA, VA and SA at different concentrations (from
0.01 till 10μg mL-1) for 24 h;
• Day 4- Reading of the fluorescence (excitation: 485 nm, emission: 538 nm,
mod. F200 Infinite, TECAN Milan, Italy)
• The levels of vascular cell adhesion molecules (VCAM-1), and endothelial
selectin (E-selectin) were measured in the supernatant by ELISA kits
following the manufacture’s instruction.
• The results derived from three indipendent experiments.
Adhesion of THP-1 to HUVECs
Protocatechuic acid (PA)
Gallic acid (GA) Vanillic acid (VA)
Syringic acid (SA)
Gut phenolic metabolites tested
Evaluation of cell adhesion molecules
Cell viability evaluation
• Cell viability assessed by trypan blue assay
• Cell viability assessed by MTT assay
The viability assay was carried out for each compound (PA, GA, VA and SA) and
for each concentration (from 0.01 till 10μg mL-1). HUVEC were incubated for 24 h
with the compounds and successively, trypan blue assay was performed in
triplicate.
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
tetrazolium reduction assay was performed on HUVECs treated with the maximum
concentration for gut phenolic metabolites. The assay was performed in triplicate










































































































































































































































































1Data are expressed as mean  SEM. Bars graph with different letters are significantly different (p≤0.05)
GA, gallic acid; PA, protocatechuic acid; SA, syringic acid; VA, vanillic acid
• GA and PA significantly decreased the production of E-selectin at 1 µg mL-1 (-
76.6%; p<0.001 for GA, -72.0%; p<0.001 for PA) and 10 µg mL-1 (-77.7%;
p<0.001 for GA, -73.8%; p<0.001 for PA) compared to TNF-. VA
significantly reduced the production of E-selectin only at the maximum
concentration (-65.1%; p<0.005). No effect was detected following SA
supplementation.
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